Robert S. Warren, M.D.
- Professor of Surgery
- Division of Surgical Oncology
- Warren Lab in Surgical Oncology
Contact Information
San Francisco, California 94143-1932
Academic Telephone: (415) 353-9294
Fax: (415) 353-9296
[email protected]
Education
- 1969-71, University of Minnesota B.A., Physiology, Magna Cum Laude
- 1976-80, University of Minnesota Medical School, Minneapolis M.D.
Residencies
- 1980-81, University of Minnesota, Intern, Surgery
- 1981-88, University of Minnesota, Resident, Surgery
Fellowships
- 1980-81, University of Minnesota, Postdoctoral Fellow, Surgery
- 1981-88, University of Minnesota, Postdoctoral Fellow, Surgery
- 1983-86, Memorial Sloan-Kettering Cancer Center, Fellow, Oncology Research
- 1983-86, Memorial Sloan-Kettering Cancer Center, Postdoctoral Fellow, Oncology
Biography
Robert S. Warren, M.D. is a Professor of Surgery and a specialist in gastrointestinal and liver cancer. He earned a medical degree at the University of Minnesota, where he completed a general surgery residency. After completing an oncology research fellowship at Memorial Sloan-Kettering Cancer Center in New York, he was an associate physician at Rockefeller University in New York. A board-certified surgeon, Dr. Warren joined UCSF Medical Center in 1988. Highly respected by his peers, Dr. Warren was named to the list of U.S. News "America's Top Doctors," a distinction reserved for the top 1% of physicians in the nation for a given specialty. His research focuses on the biology of colorectal cancer and how it spreads.
Dr. Warren is involved in clinical and laboratory research, which has centered on the biology of colorectal cancer metastasis that includes Vascular Endothelial Growth Factor (VEGF), Insulin-Like Growth Factors and Their Binding Proteins AS Modulators of Growth of Colorectal Cancer Metastases and Cytogenetics of Colorectal Cancer Metastasis. The laboratory work focuses on two areas: 1) autocrine growth factors and angiogenesis in colorectal cancer 2) molecular features which predict clinical outcome in primary and metastatic colorectal cancer.
Research Overview
- Biology of colorectal cancer metastasis
- Molecular features which predict clinical outcome in primary and metastatic colorectal cancer
- Autocrine growth factors and angiogenesis in colorectal cancer
- Vascular Endothelial Growth Factor (VEGF) Hypoxia and Colon Cancer
- Insulin-Like Growth Factors and Their Binding Proteins As Modulators of Growth of Colorectal Cancer Metastases
- Cytogenetics of Colorectal Cancer Metastasis
Research & Funding
- General Clinical Research CenterSponsor: NIH/NCRRSponsor ID: M01RR000079Funding Period:Dec 1974-Mar 2009Co-Investigator
- MOLECULAR MARKERS OF PROGNOSIS IN COLON CANCERSponsor: NIH/NCISponsor ID: R01CA084019Funding Period:Mar 2000-Feb 2006Principal Investigator
- ROLE OF CYTOKINES IN CANCER PATIENTS UNDERGOING SURGERYSponsor: NIH/NCISponsor ID: R29CA052863Funding Period:Jul 1993-Jun 1999Principal Investigator
Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 71
- Tbeileh N, Timmerman L, Mattis AN, Toriguchi K, Kasai Y, Corvera C, Nakakura E, Hirose K, Donner DB, Warren RS, Karelehto E. Metastatic colorectal adenocarcinoma tumor purity assessment from whole exome sequencing data. PLoS One. 2023; 18(4):e0271354. View in PubMed
- Antonia RJ, Karelehto E, Toriguchi K, Matli M, Warren RS, Pfeffer LM, Donner DB. STAT3 regulates inflammatory cytokine production downstream of TNFR1 by inducing expression of TNFAIP3/A20. J Cell Mol Med. 2022 08; 26(16):4591-4601. View in PubMed
- Wisneski AD, Jin C, Huang CY, Warren R, Hirose K, Nakakura EK, Corvera CU. Synchronous Versus Metachronous Colorectal Liver Metastasis Yields Similar Survival in Modern Era. J Surg Res. 2020 12; 256:476-485. View in PubMed
- Yu J, Navickas A, Asgharian H, Culbertson B, Fish L, Garcia K, Olegario JP, Dermit M, Dodel M, Hänisch B, Luo Y, Weinberg EM, Dienstmann R, Warren RS, Mardakheh FK, Goodarzi H. RBMS1 Suppresses Colon Cancer Metastasis through Targeted Stabilization of Its mRNA Regulon. Cancer Discov. 2020 09; 10(9):1410-1423. View in PubMed
- Kasai Y, Mahuron K, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Warren RS, Bergsland EK, Nakakura EK. A novel stratification of mesenteric mass involvement as a predictor of challenging mesenteric lymph node dissection by minimally invasive approach for ileal neuroendocrine tumors. J Surg Oncol. 2020 Aug; 122(2):204-211. View in PubMed
- View All Publications
In the News
- UCSF Surgical Oncology Program - - March 26, 2020Robert S. Warren, M.D. and Carlos U. Corvera, M.D. are co-Principal Investigators on a pilot grant funded through the University of California Minority Patient-Derived Xenograft (PDX) Development and Trial Center (UCaMP) to Reduce Cancer Health Disparities collaborative. Comprised of four of the University of California's NCI-designated comprehensive cancer centers: UC Davis Comprehensive Cancer Center, Jonsson Comprehensive Cancer Center at UCLA, UCSF Helen Diller Family Comprehensive Cancer [...]
